Landscapes / Targets
TNF
13 drugs act on TNF, in 32 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs13
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in China | Nov 2026soonPhase 4 trial completes | |||
| Next date | Nov 2026 · Phase 4 trial completes | ||||
| Also tested for | Crohn Disease | ||||
| Open drug page | |||||
Monoclonal antibody |
AbbVie · Public ABBV |
Approved | Sep 2027Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Rheumatoid Arthritis, Juvenile Psoriatic Arthritis and 1 more | ||||
| Open drug page | |||||
— |
Approved in China | Feb 2028Phase 4 trial completes | |||
| Next date | Feb 2028 · Phase 4 trial completes | ||||
| Also tested for | Severe Plaque Psoriasis in Chinese Children, Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease and 2 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Johnson & Johnson (Janssen) · Public JNJ |
Approved | — | ||
| How it works | An antibody | ||||
| Also tested for | Colitis, Ulcerative, Crohn's Disease | ||||
| Open drug page | |||||
Monoclonal antibody |
Johnson & Johnson (Janssen) · Public JNJ |
Approved | — | ||
| How it works | An antibody | ||||
| Also tested for | Colitis, Ulcerative | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 2/3 | Dec 2026Phase 2/3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2026 · Phase 2/3 trial completes | ||||
| Also tested for | Dry Eye Disease (DED) | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2029Phase 3 trial completes | |||
| Next date | Nov 2029 · Phase 3 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Sanofi · Public SNY |
Phase 2 | 17 Dec 2026soonPhase 2 trial completes | ||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 17 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Melanoma, Head and Neck Squamous Cell Carcinoma and 11 more | ||||
| Open drug page | |||||
STAR-LLDnot checked |
— |
Phase 1/2 | 31 May 2027Phase 1/2 trial completes | ||
| Next date | 31 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 2 | Jul 2028Phase 2 trial completes | |||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Glioblastoma, Soft Tissue Sarcoma and 4 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Sarcopenia in Elderly, Frailty and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2027Phase 1 trial completes | |||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 13 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026